© 2020 MJH Life Sciences and HCPLive. All rights reserved.
August 08, 2020
Dupilumab significantly reduces exacerbation rates in patients with asthma compared to standard of care.
In a study presented virtually at ATS 2020, investigators find 15 mg of the study drug resulted in a 43% decrease in FeNO.
August 07, 2020
A new case study assesses biopsy and autopsy tissues to characterize pathological patterns in suspected EVALI cases .
In a study presented at ATS 2020, investigators test 3 different dosing regimens of tezepelumab in asthma patients with both high and low levels of IL-5 and IL-13.
A famed virologist weighs in on the country's earliest shortcomings—and how they can still be resolved today.
August 06, 2020
A one-time intramuscular dose of the investigative drug was linked to reduced medical attention and hospitalizations related to RSV.
August 05, 2020
New findings suggest differing chronic lung diseases are associated with varying risk factors among COVID-19 patients.
August 04, 2020
World-leading virologist and AIDS researcher David Ho, MD, joins the inaugural podcast episode.
July 31, 2020
A discussion on how thromboembolism research and care could benefit from progression in diagnostics.
July 30, 2020
Patients with a mPAP of at least 19 mm Hg and pulmonary artery wedge pressure of 15 mm Hg or less had an adjusted hazard ratio for mortality of 1.71.